Sorting nexin (SNXB8), a new target for the treatment of neurodegenerative disorders, diabetes and obesity
Scientists of the LMU of Munich identified a novel member of a subgroup of the sorting nexin family, SNX-B8 also denoted as SNX-30. In the present invention this novel attributed sorting nexin activity modifies the alpha and beta secretase cleavage of amyloid precursor protein (APP) by controlling its endocytic trafficking.
Further Information: PDF
Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V.
Phone: +49 (0)89/1205-6000
Contact
Dr. Wolfgang Knappe
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Red light therapy for repairing spinal cord injury passes milestone
Patients with spinal cord injury (SCI) could benefit from a future treatment to repair nerve connections using red and near-infrared light. The method, invented by scientists at the University of…
Insect research is revolutionized by technology
New technologies can revolutionise insect research and environmental monitoring. By using DNA, images, sounds and flight patterns analysed by AI, it’s possible to gain new insights into the world of…
Expanding a lymph node, boosting a vaccine
A biomaterial vaccine enhances and sustains lymph node expansion following vaccination, boosting anti-tumor immunity in an animal model. Each one of us has around 600 lymph nodes (LNs) – small,…
